GLP-1 RA Treatment and Dosing Patterns Among Type 2 Diabetes Patients in Six Countries: A Retrospective Analysis of Pharmacy Claims Data

INTRODUCTION: The glucagon-like peptide-1 receptor agonist (GLP-1 RA) class is evolving and expanding. This retrospective database study evaluated recent real-world treatment and dosing patterns of patients with type 2 diabetes (T2D) initiating GLP-1 RAs in Belgium (BE), France (FR), Germany (DE), I...

Descripción completa

Detalles Bibliográficos
Autores principales: Divino, Victoria, Boye, Kristina S., Lebrec, Jeremie, DeKoven, Mitch, Norrbacka, Kirsi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531601/
https://www.ncbi.nlm.nih.gov/pubmed/31028689
http://dx.doi.org/10.1007/s13300-019-0615-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531601/
https://www.ncbi.nlm.nih.gov/pubmed/31028689
http://dx.doi.org/10.1007/s13300-019-0615-5

Ejemplares similares